Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	Placebo	325
Overall Study	STARTED	Pregabalin 150 mg BID	324
Overall Study	STARTED	DS-5565 15 mg QD	326
Overall Study	STARTED	DS-5565 15 mg BID	326
Overall Study	COMPLETED	Placebo	249
Overall Study	COMPLETED	Pregabalin 150 mg BID	242
Overall Study	COMPLETED	DS-5565 15 mg QD	240
Overall Study	COMPLETED	DS-5565 15 mg BID	246
Overall Study	NOT COMPLETED	Placebo	76
Overall Study	NOT COMPLETED	Pregabalin 150 mg BID	82
Overall Study	NOT COMPLETED	DS-5565 15 mg QD	86
Overall Study	NOT COMPLETED	DS-5565 15 mg BID	80

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02187471/flow